• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
White knockout Marengo logo
  • About
  • Science
  • Pipeline
  • START-001
  • START-002
  • News & Investors
  • Join Us
  • Contact Us
Back to news
11/09/2024
Press releases

Marengo Presents Promising First-in-Human Safety, Tolerability and Clinical Activity Data for its Lead Program, Invikafusp Alfa (STAR0602), at the 2024 SITC Annual Meeting

White knockout Marengo logo
Marengo Therapeutics, Inc.
840 Memorial Drive, 4th Floor
Cambridge, MA 02139
info@marengotx.com
X logo LinkedIn logo
Terms of Use Privacy Policy
© Marengo Therapeutics, Inc.
All Rights Reserved.
Great Place to Work logo
Apple Tree Partners
ATP IS DEVELOPING THE NEXT GENERATION OF
TRANSFORMATIVE LIFE SCIENCES COMPANIES.